Treatment of psychosis subsequent to phenothiazine-induced agranulocytosis.
D000328:Adult; D000368:Aged; D000380:Agranulocytosis / Q000139:chemically induced*; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002090:Butyrophenones / Q000627:therapeutic use*; D004565:Electroconvulsive Therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010640:Phenothiazines; D011618:Psychotic Disorders / Q000188:drug therapy / Q000628:therapy*; D013888:Thiothixene / Q000627:therapeutic use*
D014150:Antipsychotic Agents; D002090:Butyrophenones; D010640:Phenothiazines; D013888:Thiothixene